Study at Cambridge
About the University
Research at Cambridge
Mobile menu
Mobile menu
Privacy
Cookies
Accessibility
Search
About
About
Our team
Our performance
Careers
The Cambridge ecosystem
Partnerships and collaboration
back
For the University
For the University
Tell us your idea
Be a consultant
Develop a commercial opportunity
Start a company or social venture
Develop your skills & network
Cambridge Enterprise Academic Portal
back
For external organisations
For external organisations
Find a consultant
Opportunities to invest
International outreach
Available technologies
Available research tools
Experts & Mentors Programme
back
Latest
Latest
News
Insights
Case studies
Videos
back
What’s on
Contact us
Posts Tagged ‘Morphogen-ix’
Morphogen-ix
Share:
Annual Review
16 February 2022
Centessa Pharmaceuticals: Three portfolio companies merge into a new pharmaceutical giant
Find out more
Cambridge Enterprise
27 January 2022
2021 Annual Review reports success for Cambridge Enterprise
Find out more
Ventures
16 February 2021
Three Cambridge spin-outs join Centessa Pharmaceuticals, launched today with a $250m Series A round
Find out more
Life Sciences
18 December 2018
Spin-out Morphogen-IX raises £18.4m in a Series B financing
Find out more
Cambridge Innovation Capital
27 November 2018
Spin-out Morphogen-IX announces its clinical development candidate
Find out more
Life Sciences
28 June 2018
Spin-out Morphogen-IX announces appointment of CEO and SAB members
Find out more
Life Sciences
23 May 2016
New potential treatment for pulmonary arterial hypertension
Find out more
Life Sciences
18 January 2016
Morphogen-IX gains funding to develop treatment for pulmonary arterial hypertension
Find out more
1
Sign up to our newsletter
Stay in touch with the latest updates from Cambridge Enterprise
Sign up now